The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...

Part 2 of this two-part series on injection techniques describes the evidence base and procedure for administering a subcutaneous injection Abstract The subcutaneous route allows drugs such as insulin ...

Nucala (mepolizumab) is a brand-name subcutaneous injection that comes in different forms. Depending on which form you’re prescribed, you or your doctor will administer the injection. Nucala ...

The FDA has approved a supplemental biologics application for Leqembi Iqlik subcutaneous injection for maintenance dosing in ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA-B) partner Eisai announced today the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once weekly ...

A subcutaneous injectable form of nivolumab is available to treat melanoma, non-small cell lung cancer, renal cell cancer, and many other cancers.

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance ...

The administration of rHuPH20 increases the dispersion and absorption of immunoglobulin (IG) in the subcutaneous tissue, allowing larger volumes to be infused in the infusion site.